AU2208995A - Composition for use in raising an immune response - Google Patents

Composition for use in raising an immune response

Info

Publication number
AU2208995A
AU2208995A AU22089/95A AU2208995A AU2208995A AU 2208995 A AU2208995 A AU 2208995A AU 22089/95 A AU22089/95 A AU 22089/95A AU 2208995 A AU2208995 A AU 2208995A AU 2208995 A AU2208995 A AU 2208995A
Authority
AU
Australia
Prior art keywords
raising
composition
immune response
immune
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22089/95A
Inventor
James Chin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minister for Agriculture and Rural Affairs for State of New South
Original Assignee
MINI FOR AGRICULTURE FOR S
Minister for Agriculture and Rural Affairs for State of New South
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MINI FOR AGRICULTURE FOR S, Minister for Agriculture and Rural Affairs for State of New South filed Critical MINI FOR AGRICULTURE FOR S
Publication of AU2208995A publication Critical patent/AU2208995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU22089/95A 1994-04-12 1995-04-12 Composition for use in raising an immune response Abandoned AU2208995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM5004 1994-04-12
AUPM5004A AUPM500494A0 (en) 1994-04-12 1994-04-12 Composition for use in increasing mucosal immunity
PCT/AU1995/000206 WO1995027508A1 (en) 1994-04-12 1995-04-12 Composition for use in raising an immune response

Publications (1)

Publication Number Publication Date
AU2208995A true AU2208995A (en) 1995-10-30

Family

ID=3779584

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPM5004A Abandoned AUPM500494A0 (en) 1994-04-12 1994-04-12 Composition for use in increasing mucosal immunity
AU22089/95A Abandoned AU2208995A (en) 1994-04-12 1995-04-12 Composition for use in raising an immune response

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AUPM5004A Abandoned AUPM500494A0 (en) 1994-04-12 1994-04-12 Composition for use in increasing mucosal immunity

Country Status (3)

Country Link
AU (2) AUPM500494A0 (en)
WO (1) WO1995027508A1 (en)
ZA (1) ZA953027B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919480A (en) * 1996-06-24 1999-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal influenza vaccine composition and method
US7713942B2 (en) 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
NZ578541A (en) 2006-12-22 2012-04-27 Soluciones Biotecnologicas Innovacion Ltda Dna vaccines for fish
US8877206B2 (en) * 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
BRPI0910464B1 (en) 2008-04-17 2021-08-10 Pds Biotechnology Corporation USE OF USE OF A CHIRAL CATIONIC LIPIDIUM CONSISTING OF R-DOTAP TO PREPARE A PHARMACEUTICAL COMPOSITION
ES2689799T3 (en) * 2011-09-12 2018-11-15 Pds Biotechnology Corporation Particulate vaccine formulations
EP2897639A4 (en) 2012-09-21 2016-05-04 Frank Bedu-Addo Improved vaccine compositions and methods of use
AU2016354590B2 (en) 2015-11-13 2023-11-23 Pds Biotechnology Corporation Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
AU565313B2 (en) * 1983-10-10 1987-09-10 Biotechnology Australia Proprietary Limited Vaccine derived from pseudomonas aeruginosa
SE8405493D0 (en) * 1984-11-01 1984-11-01 Bror Morein IMMUNOGENT COMPLEX AND KITCHEN FOR PREPARING IT AND USING IT AS IMMUNOSTIMENTING AGENTS
DK166762B1 (en) * 1986-01-14 1993-07-12 Nederlanden Staat PROCEDURE FOR PREPARING IMMUNOGENIC COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPLEXES
NZ230747A (en) * 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
NL9002314A (en) * 1990-10-23 1992-05-18 Nederlanden Staat IMMUNOGENE COMPLEXES, IN PARTICULAR ISCOMS.
WO1993012240A1 (en) * 1991-12-17 1993-06-24 The Regents Of The University Of California Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)

Also Published As

Publication number Publication date
AUPM500494A0 (en) 1994-05-05
ZA953027B (en) 1996-02-19
WO1995027508A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
AU5784994A (en) Formulation for use in smokers
AU1716395A (en) Nutritional composition
AU1981095A (en) Seat elevating device
AU1462995A (en) Backrest device
AU3308195A (en) Antihypertriglyceridemic composition
AU1360395A (en) Low buffer nutritional composition
AU3002895A (en) Compositions for enhancing immune function
AU2208995A (en) Composition for use in raising an immune response
AU3621895A (en) Improvements in teats
AU749278C (en) Composition for use in dementia
AU1614495A (en) Chair
AU641516B2 (en) Back-rest
AU1324795A (en) Novel feeds for use in aquaculture
AU7997794A (en) Improvements in connecting means
AU1173892A (en) Compositions for use in dentistry
AU1209392A (en) Arrangement in pivots
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU646628B3 (en) Improvements in birdproofing
AU2813195A (en) Composition
AU3291295A (en) Composition
AU2745595A (en) Easel
AU649393B3 (en) Improvements in chairs
AUPM574394A0 (en) Improvements in piemakers
AU6622196A (en) Composition and its use
AUPM447694A0 (en) Antigen composition